FindTrial
Sign In

PRE-EMPTIVE USE OF ORAL TRAMADOL VERSUS PREGABALIN IN THE MANAGEMENT OF POSTOPERATIVE PAIN AFTER DIAGNOSTIC GYNECOLOGICAL LAPAROSCOPIC SURGERY

PRE-EMPTIVE USE OF ORAL TRAMADOL VERSUS PREGABALIN IN THE MANAGEMENT OF POSTOPERATIVE PAIN AFTER DIAGNOSTIC GYNECOLOGICAL LAPAROSCOPIC SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202011631035873
Enrollment
60
Registered
2020-11-02
Start date
2019-04-30
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain control in diagnostic laparoscopic gynecological surgery.

Interventions

Oral tramadol
Oral pregabalin
placebo

Sponsors

Department of Anesthesiology and Surgical Intensive Care Faculty of Medicine Alexandria University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ASA I or II female patients scheduled for elective diagnostic gynecological laparoscopic surgery

Exclusion criteria

Exclusion criteria: - Patient refusal - Patient inability to properly describe postoperative pain to the observer (dementia, delirium, psychiatric and neurological disorder) - Preoperative opioid or non-steroidal anti-inflammatory drug consumption or history of opioid addiction, - Allergy to pregabalin or tramadol - History of asthma or Seizures or Chronic pain syndrome.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale—

Secondary

MeasureTime frame
Total postoperative analgesic consumption,—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026